In Veritas Medical Stock Price on June 18, 2024
| IVME Stock | USD 0.0001 0.00 0.00% |
Below is the normalized historical share price chart for In Veritas Medical extending back to July 14, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of In Veritas stands at 0.0001, as last reported on the 20th of December, with the highest price reaching 0.0001 and the lowest price hitting 0.0001 during the day.
If you're considering investing in IVME Stock, it is important to understand the factors that can impact its price. We have found three technical indicators for In Veritas, which you can use to evaluate the volatility of the firm.
As of December 20, 2024, Total Stockholder Equity is expected to decline to about (6.7 M). In addition to that, Other Stockholder Equity is expected to decline to about (3.6 M). As of December 20, 2024, Price To Sales Ratio is expected to decline to 6.63. In addition to that, Price Earnings Ratio is expected to decline to -0.17. IVME Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 0.0002 | 50 Day MA 0.0001 | Beta 9.03 |
IVME |
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| IVME |
Based on monthly moving average In Veritas is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of In Veritas by adding In Veritas to a well-diversified portfolio.
Book Value (0.13) | Enterprise Value 8.6 K | Enterprise Value Ebitda (2.17) | Price Sales 0.1429 | Shares Outstanding 86 M |
Related Headline
Nexstar Broadcasting Headline on 18th of June 2024
Acquisition by Rachel Morgan of 656 shares of Nexstar Broadc... by Rachel Morgan
Filed transaction by Nexstar Broadcasting Group Officer: Evp General Counsel. Grant, award or other acquisition pursuant to Rule 16b-3(d)
In Veritas Valuation on June 18, 2024
It is possible to determine the worth of In Veritas on a given historical date. On June 18, 2024 IVME was worth 1.0E-4 at the beginning of the trading date compared to the closed value of 1.0E-4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of In Veritas stock. Still, in general, we apply an absolute valuation method to find In Veritas' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of In Veritas where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against In Veritas' related companies.
| Open | High | Low | Close | Volume | |
| 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
06/18/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 |
| 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 |
| Backtest In Veritas | | | In Veritas History | | | In Veritas Valuation | Previous | Next |
In Veritas Trading Date Momentum on June 18, 2024
| On June 20 2024 In Veritas Medical was traded for 0.0001 at the closing time. The top price for the day was 0.0001 and the lowest listed price was 0.0001 . There was no trading activity during the period 1.0. Lack of trading volume on June 20, 2024 did not cause price change. The trading delta at closing time against the current closing price is 0.00% . |
In Veritas Medical Fundamentals Correlations and Trends
By evaluating In Veritas' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among In Veritas' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. IVME financial account trend analysis is a perfect complement when working with valuation or volatility modules.About In Veritas Stock history
In Veritas investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for IVME is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in In Veritas Medical will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing In Veritas stock prices may prove useful in developing a viable investing in In Veritas
| Last Reported | Projected for Next Year | ||
| Net Loss | -3.3 M | -3.5 M |
In Veritas Stock Technical Analysis
In Veritas technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
In Veritas Period Price Range
Low | December 20, 2024
| High |
0.00 | 0.00 |
In Veritas Medical cannot be verified against its exchange. Please verify the symbol is currently traded on OTCCE Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
In Veritas December 20, 2024 Market Strength
Market strength indicators help investors to evaluate how In Veritas stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading In Veritas shares will generate the highest return on investment. By undertsting and applying In Veritas stock market strength indicators, traders can identify In Veritas Medical entry and exit signals to maximize returns
Complementary Tools for IVME Stock analysis
When running In Veritas' price analysis, check to measure In Veritas' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy In Veritas is operating at the current time. Most of In Veritas' value examination focuses on studying past and present price action to predict the probability of In Veritas' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move In Veritas' price. Additionally, you may evaluate how the addition of In Veritas to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |